Benzinga | Jul 28, 2021 04:22PM EDT

Vanda Pharmaceuticals Q2 EPS $0.17 Beats $0.14 Estimate, Sales $67.90M Miss $69.75M Estimate

Vanda Pharmaceuticals (NASDAQ:VNDA) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.14 by 21.43 percent. This is a 6.25 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $67.90 million which missed the analyst consensus estimate of $69.75 million by 2.65 percent. This is a 9.15 percent increase over sales of $62.21 million the same period last year.